Insights

Market Expansion Potential Incyte's recent FDA approvals for Zynyz in new cancer indications, such as treating advanced anal cancer, present significant market expansion opportunities for sales growth.

Cutting-Edge Medicines Portfolio With a differentiated pipeline of first-in-class medicines in Oncology, Inflammation, and Dermatology, Incyte has a strong competitive edge in offering innovative solutions to address unmet medical needs, creating appealing sales propositions.

Investor Conference Exposure Incyte's participation in high-profile investor conferences like the Goldman Sachs Healthcare Conference provides a platform to showcase their scientific approach and novel therapies, attracting potential investors and partnership opportunities that can drive sales growth.

Employee Engagement Benefits Being recognized as a top employer fosters a positive work environment and motivated workforce at Incyte, potentially translating into higher productivity and innovation in developing and promoting products, enhancing sales outcomes.

Scientific Breakthrough Presentations The acceptance of Incyte's presentations, including late-breaking data for its monoclonal antibodies, at reputable industry events like EHA 2025 highlights the company's scientific advancements and can serve as a compelling selling point to healthcare professionals and stakeholders, driving sales conversions.

Incyte Tech Stack

Incyte uses 8 technology products and services including SolarWinds, Backbone.js, Microsoft, and more. Explore Incyte's tech stack below.

  • SolarWinds
    Enterprise
  • Backbone.js
    Javascript Frameworks
  • Microsoft
    Miscellaneous
  • Windows Server
    Operating Systems
  • Planisware
    Project Management
  • New Relic
    Real User Monitoring
  • reCAPTCHA
    Security
  • Twitter
    Widgets

Media & News

Incyte's Email Address Formats

Incyte uses at least 1 format(s):
Incyte Email FormatsExamplePercentage
FLast@incyte.comJDoe@incyte.com
90%
First.Last@incyte.comJohn.Doe@incyte.com
7%
FirstL@incyte.comJohnD@incyte.com
2%
FirstLast@incyte.comJohnDoe@incyte.com
1%

Frequently Asked Questions

Where is Incyte's headquarters located?

Minus sign iconPlus sign icon
Incyte's main headquarters is located at 1801 Augustine Cut-Off Wilmington, Delaware 19803 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Incyte's phone number?

Minus sign iconPlus sign icon
You can contact Incyte's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Incyte's stock symbol?

Minus sign iconPlus sign icon
Incyte is a publicly traded company; the company's stock symbol is INCY.

What is Incyte's official website and social media links?

Minus sign iconPlus sign icon
Incyte's official website is incyte.com and has social profiles on LinkedIn.

How much revenue does Incyte generate?

Minus sign iconPlus sign icon
As of June 2025, Incyte's annual revenue reached $3.7B.

What is Incyte's NAICS code?

Minus sign iconPlus sign icon
Incyte's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Incyte have currently?

Minus sign iconPlus sign icon
As of June 2025, Incyte has approximately 3.1K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: P. D.Chief Medical Officer: S. S.Chief Technology Officer: D. J.. Explore Incyte's employee directory with LeadIQ.

What industry does Incyte belong to?

Minus sign iconPlus sign icon
Incyte operates in the Pharmaceutical Manufacturing industry.

What technology does Incyte use?

Minus sign iconPlus sign icon
Incyte's tech stack includes SolarWindsBackbone.jsMicrosoftWindows ServerPlaniswareNew RelicreCAPTCHATwitter.

What is Incyte's email format?

Minus sign iconPlus sign icon
Incyte's email format typically follows the pattern of . Find more Incyte email formats with LeadIQ.
Incyte

Incyte

Pharmaceutical ManufacturingDelaware, United States1001-5000 Employees

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs through the discovery, development and commercialization of innovative medicines.

Since 2002, Incyte has been committed to the relentless pursuit of science to improve the lives of patients and drive meaningful advances in healthcare. 

Incyte’s unique expertise in medicinal chemistry and biology has enabled us to build a portfolio of first-in-class medicines and a differentiated pipeline of therapies in Oncology and Inflammation & Autoimmunity, including Dermatology. The majority of our clinical candidates were discovered by Incyte scientists.

Headquartered in Wilmington, Delaware, Incyte has more than 2,600 employees and operations in North America, Europe and Asia. 

We are proud to have been named a top five employer by Science magazine for 7 consecutive years, as well as being named one of America’s 100 Most Loved Workplaces and one of the Most Loved Global Workplaces by Newsweek.

For additional information on Incyte, please visit Incyte.com or follow us on social media: X, Instagram, Facebook, YouTube.

See our Community Guidelines: http://bit.ly/2sV0H5W

Section iconCompany Overview

Headquarters
1801 Augustine Cut-Off Wilmington, Delaware 19803 US
Phone number
Website
incyte.com
Stock Symbol
INCY
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconFunding & Financials

  • $1B

    Incyte's revenue is in the range of $1B

Section iconFunding & Financials

  • $1B

    Incyte's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.